Popped 23% at the open..
Canopy to source cannabis formulations from Delivra
2016-09-19 08:42 ET - News Release
See News Release (C-CGC) Canopy Growth Corp
Mr. Bruce Linton of Canopy reports
CANOPY GROWTH AND DELIVRA PARTNER TO OFFER INNOVATIVE THERAPEUTIC CANNABIS PRODUCTS
Canopy Growth Corp. has entered into an agreement with Delivra Inc. to supply Canopy Growth's operating subsidiaries, including Tweed Inc. and Bedrocan Canada Inc., with cannabis-infused topical product formulations.
Topical cannabis products have proven market demand but have yet to be created for the legal medical cannabis market in Canada. By teaming with Delivra, Tweed will be able to offer customers a unique product suite, produced to exacting standards and presented alongside a wide and growing range of cannabis options. Delivra has created a new topical formulation for this express purpose, to be made exclusively available in Canada from Tweed.
"Our product lines are about variety," said Bruce Linton, Chairman and CEO of Canopy Growth. "Increasingly, variety means more than dried cannabis strains. It means lotions, pills, and other forms of cannabinoid delivery that don't involve inhaling smoke. Delivra has built a reputation for innovative and proven leadership in transdermal applications and we're pleased to be working with them to provide a best-in-class cannabis delivery solution for our Canadian customers."
Delivra and Canopy Growth are also collaborating on a series of studies to reinforce the body of scientific evidence surrounding the transdermal application of cannabinoids. The companies anticipate that transdermal cannabinoids could be an effective therapeutic option for a range of conditions.
"Cannabinoid therapy is a rapidly emerging field of medicine, quickly demonstrating its applicability to a range of acute and chronic indications, in particular those related to pain management", said Dr. Joe Gabriele, founder and CEO of Delivra. "We are very pleased to be working with Canopy Growth, the Canadian market leader, to provide innovative topical solutions, both for localized and systemic delivery, according to the need of the patient and the condition."